Could endothelial caveolae be the target of general anaesthetics?

British Journal of Anaesthesia

Volumn 96, Issue 5, 2006, Pages 547-550

  Parat, M O ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ALBUMIN; ANESTHETIC AGENT; CALCIUM; CAVEOLIN 1; CHOLESTEROL; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; FILIPIN; HALOTHANE; INSULIN; LOW DENSITY LIPOPROTEIN; METHYL BETA CYCLODEXTRIN; NITRIC OXIDE; NYSTATIN; OXIDIZED LOW DENSITY LIPOPROTEIN; PROPOFOL; PROSTACYCLIN; THROMBOXANE;

BLOOD PRESSURE; BLOOD VESSEL PERMEABILITY; CALCIUM SIGNALING; CARDIOVASCULAR FUNCTION; CAVEOLA; CORONARY ARTERY BLOOD FLOW; DRUG TARGETING; EDITORIAL; ENDOTHELIUM CELL; HEART HEMODYNAMICS; HEART OUTPUT; HEART RATE; HEART RIGHT ATRIUM PRESSURE; HEART STROKE VOLUME; HOMEOSTASIS; HUMAN; LIPID COMPOSITION; NONHUMAN; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; PROTEIN INTERACTION; TRANSCYTOSIS; VASCULAR RESISTANCE; VASODILATATION;

EID: 33645857050     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/ael079     Document Type: Editorial

References (25)

1. Az-ma T, Fujii K, Yuge O. Inhibitory effect of sevoflurane on nitric oxide release from cultured endothelial cells. Eur J Pharmacol 1995; 289: 33-9
2. Heindl B, Reichle F, Beckert BF. Sevoflurane but not isoflurane can reduce prostacyclin production of endothelial cells. Eur J Anaesthesiol 2003; 20: 116-19
3. Lischke V, Busse R, Hecker M. Volatile and intravenous anesthetics selectively attenuate the release of endothelium-derived hyperpolarizing factor elicited by bradykinin in the coronary microcirculation. Naunyn Schmiedebergs Arch Pharmacol 1995; 352: 346-9
4. Arriero MM, Munoz AL, Lopez-Farre A, et al. Sevoflurane reduces endothelium-dependent vasorelaxation: Role of superoxide anion and endothelin. Can J Anaesth 2002; 49: 471-6
5. Heindl B, Conzen PF, Becker BF. The volatile anesthetic sevoflurane mitigates cardiodepressive effects of platelets in reperfused hearts. Basic Res Cardiol 1999; 94: 102-11
6. Petros AJ, Bogle RG, Pearson JD. Propofol stimulates nitric oxide release from cultured porcine aortic endothelial cells. Br J Pharmacol 1993; 109: 6-7
7. Park KW, Dai HB, Lowenstein E, Sellke FW. Propofol-associated dilation of rat distal coronary arteries is mediated by multiple substances, including endothelium-derived nitric oxide. Anesth Analg 1995; 81: 1191-6
8. Karashima Y, Oike M, Takahashi S, Ito Y. Propofol prevents endothelial dysfunction induced by glucose overload. Br J Pharmacol 2002; 137: 683-91
9. Horibe M, Ogawa K, Sohn JT, Murray PA. Propofol attenuates acetylcholine-induced pulmonary vasorelaxation: Role of nitric oxide and endothelium-derived hyperpolarizing factors. Anesthesiology 2000; 93: 447-55
10. Spisni E, Griffoni C, Santi S, et al. Colocalization prostacyclin (PGI2) synthase - caveolin-I in endothelial cells and new roles for PGI2 in angiogenesis. Exp Cell Res 2001; 266: 31-43
11. Bucci M, Gratton JP, Rudic RD, et al. In vivo delivery of the caveolin-I scaffolding domain inhibits nitric oxide synthesis and reduces inflammation. Nat Med 2000; 6: 1362-7
12. Kanna T, Akata T, Izumi K, et al. Sevoflurane and bradykinin-induced calcium mobilization in pulmonary arterial valvular endothelial cells in situ: Sevoflurane stimulates plasmalemmal calcium influx into endothelial cells. J Cardiovasc Pharmacol 2002; 40: 714-24
13. 2+ influx in primary human endothelial cells. Anesth Analg 2003; 97: 430-5
14. 2+ entry. J Biol Chem 2000; 275: 17979-85
15. Isshiki M, Ying YS, Fujita T, Anderson RG. A molecular sensor detects signal transduction from caveolae in living cells. J Biol Chem 2002; 277: 43389-98
16. Hu G, Albrecht RF, Salem MR, Crystal GJ, Minshall RD. Isoflurane, but not sevoflurane, increases transcellular albumin permeability in pulmonary microvascular endothelial cells. Anesthesiology 2004; 101: A1581
17. Smart EJ, Anderson RG. Alterations in membrane cholesterol that affect structure and function of caveolae. Methods Enzymol 2002; 353: 131-9
18. Ueda I, Hirakawa M, Arakawa K, Kamaya H. Do anesthetics fluidize membranes? Anesthesiology 1986; 64: 67-71
19. Tsuchiya H. Structure-specific membrane-fluidizing effect of propofol. Clin Exp Pharmacol Physiol 2001; 28: 292-9
20. Norman RI, Hirst R, Appadu BL, et al. Anaesthetic potency of inhalation agents is independent of membrane microviscosity. Br J Anaesth 1997; 78: 290-5
21. Okuda C. The effects of volatile anesthetics on the binding of 1-anilino-8-naphthalene sulphonate to biological membranes and lipid vesicles: The role of cholesterol. J Biochem (Tokyo) 1982; 92: 357-63
22. Mastrangelo CJ, Trudell JR, Edmunds HN, Cohen EN. Effect of clinical concentrations of halothane on phospholipid-cholesterol membrane fluidity. Mol Pharmacol 1978; 14: 463-7
23. Morgan PG, Hubbard M, Eckenhoff RG, Sedensky MM. Halothane partitions to lipid rafts in C. elegans. Anesthesiology 2004; 101: A105
24. Sbaa E, Frerart F, Feron O. The double regulation of endothelial nitric oxide synthase by caveolae and caveolin: A paradox solved through the study of angiogenesis. Trends Cardiovasc Med 2005; 15: 157-62
25. Schubert W, Frank PG, Woodman SE, et al. Microvascular hyperpermeability in caveolin-1 (-/-) knock-out mice. Treatment with a specific nitric-oxide synthase inhibitor, L-name, restores normal microvascular permeability in Cav-1 null mice. J Biol Chem 2002; 277: 40091-8